Petrylak DP, Balar AV, O'Donnell PH, et al. EV-201: Results of enfortumab vedotin monotherapy for locally advanced or metastatic urothelial cancer previously treated with platinum and immune checkpoint inhibitors. ASCO Annual Meeting 2019, abstract LBA4505.
Encorafenib en binimetinib bij niet-resectabel of gemetastaseerd BRAF-gemuteerd melanoom
apr 2019 | Dermato-oncologie